BioMérieux S.A.
BIM
株式のランク
#1770
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
株価
$103.14
時価総額
$12.14B
変化（1日）
-0.34%
変化（1年）
-19.81%
国
FR
取引 BioMérieux S.A. (BIM)
カテゴリー
Healthcare
BioMérieux S.A.（BIM）のEPS
June 2026 時点のEPS TTM: $4.66
BioMérieux S.A.の最新の財務報告と株価によると、同社の現在のEPS（TTM）は$4.66です。2023年末には、EPSは$3.35で、2022年のEPS$4.12と減少でした。
BioMérieux S.A.のEPS履歴（2005から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $4.66 | 22.03% |
| 2024 | $3.82 | 14.01% |
| 2023 | $3.35 | -18.68% |
| 2022 | $4.12 | -28.69% |
| 2021 | $5.78 | 38.69% |
| 2020 | $4.17 | 60.70% |
| 2019 | $2.59 | 3.46% |
| 2018 | $2.51 | 3.36% |
| 2017 | $2.42 | 52.56% |
| 2016 | $1.59 | 57.34% |
| 2015 | $1.01 | -26.79% |
| 2014 | $1.38 | -27.84% |
| 2013 | $1.91 | 27.11% |
| 2012 | $1.50 | -13.31% |
| 2011 | $1.73 | -3.18% |
| 2010 | $1.79 | -0.04% |
| 2009 | $1.79 | 16.91% |
| 2008 | $1.53 | 26.36% |
| 2007 | $1.21 | 3.59% |
| 2006 | $1.17 | 30.41% |
| 2005 | $0.90 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| $18.62 | 299.43% |
US
|
|
| $5.65 | 21.20% |
US
|
|
| $-1.36 | -129.17% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 9.19% |
US
|
